Trial intelligence / Profile preview

Landiolol for Prevention of Atrial Fibrillation After Cardiac Surgery

NCT05084118Phase 3Unknown

Sponsor
Medical University of Vienna
Start
Oct 2021
Primary completion
Nov 2023
Countries
1
01

Overview

A Phase 3 trial of landiolol in Atrial fibrillation (AFib), sponsored by Medical University of Vienna. Status: unknown.

02

Drugs

landiolol
03

Conditions

Atrial fibrillation (AFib)

Beyond the preview

Go deeper on NCT05084118.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05084118.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call